This section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Article content

Sign In or Create an Account

or View more offersArticle content

OTTAWA, Ontario — Best Cyclotron Systems (BCS), a TeamBest Global (TBG) company with locations in Ottawa and Vancouver, Canada, and Knoxville, Tennessee, USA, is pleased to announce the successful completion in July of Factory Acceptance Tests (FAT) for the Best 70-MeV high-current proton cyclotron (B-70), a state-of-the-art accelerator designed, developed, and manufactured by TeamBest engineers and scientists in Canada.

Article contentWe apologize, but this video has failed to load.Try refreshing your browser, or
tap here to see other videos from our team.Article content

The B-70 will be shipped to the National Atomic Research Institute (NARI) in Taoyuan City, Taiwan. Installation and project completion are expected in 2027.

Article content

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

TBG’s technology portfolio spans 6 MeV research cyclotrons with high proton current to high-energy 70 MeV multi-particle systems. The B-70 underscores Best’s continued commitment to advancing high-current proton and multi-particle alpha/deuteron/proton (adp) cyclotron technology and expanding access to accelerator-based radioisotope production and research capabilities. BCS is currently manufacturing 10+ cyclotrons of various energies for global customers while expanding facilities across North America, Europe, and India. BCS has manufactured and installed nearly 40 advanced medical cyclotrons and expects to produce more than ten cyclotrons annually beginning next year, contributing to production of radioisotopes for nuclear medicine and radiotherapy, as well as neutron production and fundamental particle research.

Article contentArticle content

Recently, BCS celebrated the 16th anniversary of winning its first international tender for a high-current proton cyclotron for INFN in Italy in 2010. In 2016, BCS commissioned the B-70 cyclotron at INFN Legnaro, Italy. Building on that success, Best ABT developed the BG-95 and B-11 cyclotrons, optimized for on-site production of PET tracers, including F-18, N-13, C-11, and Ga-68—crucial for imaging in cardiology, oncology, and neurology. Their compact, shielded designs allow seamless installation adjacent to clinical imaging suites, improving workflow and expanding patient access to cutting-edge diagnostics. TBG’s cyclotrons are engineered for the safe, high-yield production of essential radioisotopes, including Technetium-99m—a cornerstone of nuclear imaging—as well as emerging isotopes that enable targeted cancer therapies.

Article content

BCS is also developing a 200 MeV variable-energy cyclotron proton therapy system for treating medical conditions such as pediatric, eye, head/neck, breast, lung, brain and pancreatic cancers, neurological/cardiovascular abnormalities and other medical ailments.

Article content

In addition, Best Particle Therapy, Inc. has designed the Ion Rapid Cycling Medical Synchrotron (iRCMS) for protons, carbon, and heavier ions, offering cancer patients exceptional treatment flexibility. In comparison to slow-cycling synchrotrons and cyclotrons, the iRCMS is faster, lighter, more accurate, and compatible with proton, carbon, simple, and future modalities.

Article content

Each week, Best ABT/Best Cyclotron supports the delivery of thousands of radiopharmaceutical doses worldwide, helping clinicians detect disease earlier and make more informed treatment decisions. Through a continued commitment to innovation, TBG has helped advance the field of nuclear medicine for nearly two decades. From pioneering cyclotron technologies to expanding particle capabilities to include alpha and deuteron production, TeamBest continues to push the boundaries of what is possible—advancing global health, strengthening technological excellence, and laying the foundation for the next generation of breakthroughs.

Article contentArticle contentArticle contentArticle contentView source version on businesswire.com: Article content

https://www.businesswire.com/news/home/20260910274264/en/

Article contentArticle content

Contacts

Article contentThis advertisement has not loaded yet.Trending


  1. CRA denies tax credit to B.C. divorced dad paying child and spousal support

    Personal Finance


  2. Canada can afford to wait out Trump’s trade war, say two prominent policy vets

    Economy

  3. Story continues belowThis advertisement has not loaded yet, but your article continues below.

  4. EU and Canada plan deal to boost trade, security as U.S. ties fray

    News


  5. Posthaste: Tariff ‘double whammy’ headed straight for these Canadian businesses, report says

    News


  6. How worried should variable-rate borrowers be about Bank of Canada rate hikes?

    Mortgages